Related Experiment Video
Updated: Jun 7, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
[Epidemiology of maternal-fetal group B streptococcal infections]
E Ben Hamida Nouaili1, K Abidi, S Chaouachi
1Service de néonatologie, hôpital Charles-Nicolle, Tunis, Tunisie. emira@ben-hamida.com
Goal:
The aim of this study was to determine the incidence, risk factors, and outcome of maternal-fetal infection due to group B streptococcus.
Patients And Methods:
We identified all cases of maternal-fetal group B streptococcus infection between January 2003 and December 2007, from neonatal unit reports at the Charles Nicolle Hospital.
Results:
Ninety cases were identified out of 17,922 live births, incidence 5 ‰ of which 2.3 ‰ of bacteremia. Twenty percent of all newborns were premature and 22.2% had a low birth weight. Peripartum maternal fever was recorded in 52.2% of cases and membrane rupture more than 12 hours before delivery occurred in 74.4%. Among the newborns, 45.6% were symptomatic at birth. Forty percent of group B streptococci were resistant to erythromycin and 3.3% with intermediate resistance to ampicillin. The global neonatal mortality after group B streptococcus infection was 3.3%.
Conclusion:
Maternal-fetal infection due to group B streptococcus is still frequent and continues to be a major cause of morbidity and mortality.
Related Concept Videos
Development of the Oral Microbiota
Development of Human Microbiota
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Clinical Significance of Antibiotic Resistance
